Triple therapy AMD trial to continue

Article

The Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) is to continue as planned, following promising interim results and the positive recommendations of the independent Data and Safety Monitoring Committee.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Related Content
A person stands in front of a white screen, facing an audience. The speaker and audience are visible in silhouette. Concept image for European Society of Retina Specialists (EURETINA) clinical trial data presentation. Logos courtesy of EURETINA, Ashvattha Therapeutics, Clearside Biomedical and Carl Zeiss Medical Technology. Background image courtesy of TezcanKemal, Getty Images. Created with Canva.

Ashvattha Therapeutics, Clearside Biomedical, ZEISS preview EURETINA presentations

Kassi Filkins
August 29th 2025
Article
PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

August 29th 2025
Podcast
A person speaks on a stage during a conference/lecture. Concept image for 2025 EURETINA European Society of Retina specialists scientific meeting. Image credit: ©Anton Gvozdikov – stock.adobe.com

The Eye Care Network's clinical advisors will present at EURETINA

Hattie Hayes
August 29th 2025
Article
PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

August 29th 2025
Podcast
Concept image for the balancing of energy efficiency and time in refractive surgery phacoemulsification. A scale, with a laser beam of blue light on one side, and an analog alarm clock on the other side. The laser beam of blue light is surrounded by static. Created with Canva Magic AI.

Keys to optimising phaco efficiency

Marta Ibarz, MD, PhD
August 29th 2025
Article
European Union flags outside the Berlaymont building in Brussels, Belgium, the headquarters of the European Commission. Concept image for ZEISS Medical Technology CE Mark CIRRUS PathFinder AI. Image credit: © olrat – stock.adobe.com

European Commission issues CE mark for Zeiss CIRRUS PathFinder AI tool

Hattie Hayes
August 29th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.